advancing innovation to save lives

The Hill features op-ed from GHTC director

The Hill featured an op-ed from GHTC Director Jamie Bay Nishi which highlights the historic decline in US government investment in neglected disease R&D and calls for the US to increase funding and reassert American leadership in global health innovation.
View

Pipeline of Promise

Learn about the global health R&D process through our interactive Pipeline of Promise infographic.
Learn More

International Partnership For Microbicides

The International Partnerships for Microbicides (IPM) is a nonprofit organization that developed the monthly dapivirine ring, and is dedicated to accelerating the development and availability of other new HIV prevention tools for women in developing countries.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC
GHTC issues statement on WHO R&D observatory, pooled fund at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session supporting the rapid establishment and full funding for the World Health Organization (WHO) Global Observatory on Health Research and Development, as well as ongoing efforts to establish a pooled fund. The statement, issued with PATH, also calls for transparency to ensure the fund’s foundation is sound science and public health.

PDF
GHTC
GHTC issues statement on antimicrobial resistance at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session welcoming the World Health Organization’s (WHO) efforts to combat antimicrobial drug resistance (AMR). The statement, issues with PATH, calls on the US government to support these efforts, with a focus on prioritizing development of a range of new tools, as well as to support the establishment of the Global Antimicrobial Surveillance System.

PDF
View All News & Events

Community Event

McGill University
McGill Summer Institute in Infectious Diseases and Global Health
McGill University
Learn More
View All Events
Photo: White house/Shealah Craighead
Medical research, global health programs face steep cuts in Trump budget

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

Read More
CDC/Dr. Scott Smith
G20 health ministers pledge support for R&D to combat antimicrobial resistance, pandemic threats

Health ministers from G20 nations, meeting for the first time, pledged to work together to combat antimicrobial resistance and improve pandemic preparedness, emphasizing the critical role research and development plays in confronting these global challenges.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide